Debut Plus

₹1.9

▲ +0.09 +4.97%

18 Jul 2026

BSE Listed

GSM 4

Advik Laboratories Ltd. (531686)

Volume: 854Avg Vol 1W: 936Avg Vol 1M: 9,14952W Range:₹1.57₹2.72
BSE www.mpspharmaa.com
Key Ratios
Checked 4h ago
Market Cap₹4 Cr
Current Price₹1.9
Previous Close₹1.81
High / Low (52w)₹2.72 / ₹1.57
Volume854
Avg Vol (1W)936
Avg Vol (1M)9,149
Stock P/E—
Book Value₹0.04
Dividend Yield0%
ROE-1,489.05%
ROA-12.03%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹0
P/B50.86
Debt / Equity4.83
50 DMA₹2.05
200 DMA—
Day change+4.97%
SurveillanceGSM 4 (as of 2026-07-18)
Price Chart
₹1.9▼ 26.64% · 1Y
₹4₹299K
2025-07-21
2026-07-13

20-day avg volume: 10K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 49% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹4 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹-1 Cr₹-1 Cr₹-1 Cr₹-4 Cr₹-1 Cr₹-1 Cr₹-1 Cr₹-1 Cr
Net Profit₹-1 Cr₹-1 Cr₹-1 Cr₹-4 Cr₹0 Cr₹-1 Cr₹-1 Cr₹-1 Cr
EPS-0.44-0.65-0.61-2.31-0.07-0.55-0.43-0.47
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹19 Cr₹18 Cr₹16 Cr₹11 Cr₹10 Cr₹10 Cr₹10 Cr₹9 Cr
Total Liabilities₹8 Cr₹8 Cr₹8 Cr₹7 Cr₹6 Cr₹7 Cr₹8 Cr₹8 Cr
Equity₹11 Cr₹10 Cr₹8 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹-4 Cr₹-1 Cr₹-1 Cr₹-1 Cr
Investing₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹-1 Cr₹4 Cr₹1 Cr₹1 Cr₹0 Cr
Free Cash Flow₹-1 Cr₹-4 Cr₹-1 Cr₹-1 Cr₹-1 Cr
Shareholding
Promoter 35.89% Institutions 0.58% Public 63.53%
Efficiency & Working Capital
ROCE-13.9%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-03-31

Promoter35.9%
FII0%
DII0.6%
Institutions0.6%
Public63.5%
Promoter Pledge16%
No. of Shareholders4,419
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters35.9%35.9%35.9%35.9%35.9%35.9%35.9%35.9%35.9%35.9%35.9%35.9%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.6%0.6%0%0.6%0.6%0.6%0.6%0.6%0.6%0.6%0.6%0.6%
Public63.5%63.5%64.1%63.5%63.5%63.5%63.5%63.5%63.5%63.5%63.5%63.5%
Promoter Pledge16%16%16%16%16%16%16%16%16%16%16%16%
No. of Shareholders4,4754,4544,4354,4144,3984,3864,3974,4224,4454,4334,4254,419
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Omkam Pharmaceuticals Private LimitedShareholding of Promoter and Promoter Group25.7%49,02,322
Pataliputra International LimitedPublic Shareholding17.5%33,47,325
Peeyush Kumar AggarwalShareholding of Promoter and Promoter Group10.2%19,57,159
Sangeetha SPublic Shareholding6.2%11,89,720
Dhiru Builders And Promoters Private LimitedPublic Shareholding5.2%10,00,000
Sneha GargPublic Shareholding2%3,85,000
Geeta GargPublic Shareholding2%3,80,000
Sampark Securities Pvt LtdPublic Shareholding1.1%2,03,229
Ajay Sharma (independent Director)Public Shareholding0%10
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Peeyush Kumar Aggarwal00%2026-03-31
Omkam Pharmaceuticals Private Limited11,00,00022.4%2026-03-31
Geeta Garg00%2026-03-31
Sneha Garg00%2026-03-31
Sangeetha S00%2026-03-31
Pataliputra International Limited00%2026-03-31
Dhiru Builders And Promoters Private Limited00%2026-03-31
Sampark Securities Pvt Ltd00%2026-03-31
Ajay Sharma (independent Director)00%2026-03-31
Peeyush Kumar Aggarwal00%2025-12-31
Omkam Pharmaceuticals Private Limited11,00,00022.4%2025-12-31
Geeta Garg00%2025-12-31
Board of Directors
NameDesignationYear
Peeyush Kumar AggarwalChairman / Executive Director / M D / Promoter2025
Madhu SharmaIndependent Non Exe. Director2025
Ram Niwas SharmaNon-Exec & Non-Independent Dir2025
Ajay SharmaIndependent Non Exe. Director2025
Pooja ChuniCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
In India₹1 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10202019
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000000
2025000000
2025000000
Substantial Acquisitions (SAST)

6 disclosure(s)

Market12/07/2021 · 42,12,325
Market12/07/2021 · 42,12,325
Market12/07/2021 · 26,29,000
Market & Off Market12/07/2021 · 26,29,000
Off Market12/07/2021 · 16,05,270
Off Market12/07/2021 · 16,05,270
Company Information
Incorporated1994
ChairmanPeeyush Kumar Aggarwal
AuditorNemani Garg Agarwal & Co
Investor Email[email protected], [email protected]
🌐 www.mpspharmaa.com ↗

📍 138 Roz-Ka-Meo Industrial Area, Sohna, Mewat, Haryana, 122103

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Anka India Ltd.Emrock Corporation LimitedAris International Ltd.Mayur Leather Products Ltd.Amerise Biosciences LimitedFrontline Financial ServiPrithvi Exchange (India)Khyati Multimedia-EntertaRainbow Foundations Ltd.VSD Confin Ltd.Tricom Fruit Products LimitedVidhi Specialty Food IngredientsAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search